Regulatory News
Wednesday, November 16, 2016
Roche, Bristol-Myers cut cancer drug prices to win UK approval
LONDON, Nov 17 (Reuters) - Roche and Bristol-Myers
Squibb on Thursday became the latest drugmakers to cut
the price of cancer medicines in order to secure access to
Britain's National Health Service.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment